Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cbd - search results
If you're not happy with the results, please do another search
The FDA’s 2020 Cannabis policy
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
The European Green Deal: Biodiversity can’t wait
President of the Study Group on The sustainable economy we need at EESC, Josep Puxeu Rocamora, argues that when it comes to the European Green Deal, biodiversity cannot wait.
Removing the barriers to ensure a thriving UK hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance, explains what we need to know about removing the barriers to ensure a thriving UK hemp industry.
Topical Cannabis-Based Medicines (TCBM): A novel epigenetic paradigm for wound management
Dr Vincent Maida discusses his discoveries and pioneering research in the area of using Topical Cannabis-Based Medicines (TCBM) for integumentary and wound management.
How can medical marijuana help people lose weight?
Michael Jacobs, marketing and creative content specialist at GotVape.com offers his insight into how medical marijuana has the potential to help people lose weight.
CND session of March 2020: Low THC products?
Here Kathleen Denoodt explains the role of ECDD and why she believes the recommendations of the investigative report should be followed.
What is the Europe Canna Expo?
Kristina Spionjak discusses what will happen at Europe Canna Expo 2020, and reflects on opportunities for the medical cannabis industry.
Cannabis-based medicines as a treatment for epilepsy in the UK
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
Seeding the future of the British hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance takes a close look at the future of the British hemp industry in this article.
January 2020 North America Analysis
The January 2020 edition of North America Analysis boasts a wide array of content on policy issues from the region, including a special feature from Dr Suresh Kuppuswamy at Frost & Sullivan, who explores the future of medical imaging.
Healing with cannabinoids: MS and Prostate Cancer
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
How can cannabis help in treating anxiety?
Today, people use cannabis products such as CBD for numerous medicinal benefits, here we find out how it can help in treating anxiety.
Medical use of cannabinoids and marijuana
In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.
Bioavailibity: Oils, capsules, vapes, gummies and balms
Here, we have a brief look at the different methods of using CBD, and how each method affects bioavailability.
What next for the UK’s cannabis laws?
John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.
From Cannabis flower to final products: Extractions for Phytopharmaceuticals
Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
NIMH: The largest research organisation for mental illness in the world
The work of the National Institute of Mental Health (NIMH) in the U.S. is charted here, which we find out is the largest research organisation for mental illness in the world.
The UK’s medical cannabis industry
Dr. Frank D'Ambrosio, CMO of Block Commodities Plc, provides an insight into the UK’s medical cannabis industry.
Closing gaps in cannabinoid research to make progress in pain management
David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health (NIH), shares his thoughts on closing gaps in cannabinoid research to make progress in pain management.
The value of accreditation in the cannabis industry
Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.
